Rapidly progressing breast cancer (poussée évolutive) in Tunisia: studies on delayed hypersensitivity. 1978

N Mourali, and P H Levine, and F Tabanne, and S Belhassen, and J Bahi, and M Bennaceur, and R B Herberman

Delayed hypersensitivity reactions to a battery of antigens were measured in 145 Tunisian breast cancer patients to determine whether an immunologic mechanism could be detected which might explain the high frequency (60%) of the rapidly progressing form in Tunisian breast cancer patients. Although a greater proportion (30%) of patients with rapily progressing breast cancer reacted to extracts of a breast tumor antigen (2937) than patients without PEV (9%), no significnat difference between PEV and non-PEV patients could be found in reactivity to DNCB, standard microbial antigens, or extracts from tissue culture cell lines. Rapidly progressing breast cancer in Tunisia is not associated with an impairment of delayed hypersensitivity.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004137 Dinitrochlorobenzene A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds. 1-Chloro-2,4-Dinitrobenzene,2,4-Dinitrochlorobenzene,Benzene, 1-Chloro-2,4-Dinitro-,Chlorodinitrobenzene,DNCB,1 Chloro 2,4 Dinitrobenzene,2,4 Dinitrochlorobenzene
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin
D014416 Tunisia A country in northern Africa between ALGERIA and LIBYA. Its capital is Tunis.

Related Publications

N Mourali, and P H Levine, and F Tabanne, and S Belhassen, and J Bahi, and M Bennaceur, and R B Herberman
July 1977, Cancer,
N Mourali, and P H Levine, and F Tabanne, and S Belhassen, and J Bahi, and M Bennaceur, and R B Herberman
December 1987, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
N Mourali, and P H Levine, and F Tabanne, and S Belhassen, and J Bahi, and M Bennaceur, and R B Herberman
November 1968, The British journal of surgery,
N Mourali, and P H Levine, and F Tabanne, and S Belhassen, and J Bahi, and M Bennaceur, and R B Herberman
July 1974, The British journal of surgery,
N Mourali, and P H Levine, and F Tabanne, and S Belhassen, and J Bahi, and M Bennaceur, and R B Herberman
December 1983, Presse medicale (Paris, France : 1983),
N Mourali, and P H Levine, and F Tabanne, and S Belhassen, and J Bahi, and M Bennaceur, and R B Herberman
January 1978, Neoplasma,
N Mourali, and P H Levine, and F Tabanne, and S Belhassen, and J Bahi, and M Bennaceur, and R B Herberman
January 1988, Journal of the Indian Medical Association,
N Mourali, and P H Levine, and F Tabanne, and S Belhassen, and J Bahi, and M Bennaceur, and R B Herberman
March 1970, Clinical science,
N Mourali, and P H Levine, and F Tabanne, and S Belhassen, and J Bahi, and M Bennaceur, and R B Herberman
November 1962, The Journal of clinical investigation,
N Mourali, and P H Levine, and F Tabanne, and S Belhassen, and J Bahi, and M Bennaceur, and R B Herberman
January 1995, Terapevticheskii arkhiv,
Copied contents to your clipboard!